| |
| |
|
| Insider
Information: |
Fernandez Henry A |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,796,528 |
|
|
Indirect Shares
|
73,600 |
|
|
| Direct
Value |
$840,033,098 |
|
|
|
Indirect Value
|
$8,966,906 |
|
|
| Total
Shares |
1,870,128 |
|
|
| Total
Value |
$849,000,004 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 0.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Msci Inc |
MSCI |
Chairman and CEO, Dire... |
2024-04-25 |
1,745,267 |
2024-04-25 |
15,400 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-06-07 |
51,261 |
2024-06-07 |
58,200 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-06-30 |
4 |
A |
$41.52 |
$37,493 |
D/D |
903 |
26,131 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-09-30 |
4 |
A |
$41.06 |
$37,490 |
D/D |
913 |
27,044 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-12-30 |
4 |
A |
$39.76 |
$37,495 |
D/D |
943 |
27,987 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2023-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,472 |
1,239,585 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2023-02-08 |
4 |
D |
$556.90 |
$8,768,947 |
D/D |
(15,746) |
1,223,839 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,747 |
36,783 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-30 |
4 |
A |
$31.03 |
$37,481 |
D/D |
1,208 |
37,991 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-09-29 |
4 |
A |
$27.08 |
$37,475 |
D/D |
1,384 |
39,375 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-12-29 |
4 |
A |
$27.71 |
$37,493 |
D/D |
1,353 |
40,728 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2024-02-05 |
4 |
D |
$583.39 |
$29,461,778 |
D/D |
(50,501) |
1,516,224 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2024-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
91,320 |
1,520,260 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-03-28 |
4 |
A |
$30.23 |
$37,483 |
D/D |
1,240 |
41,968 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2024-04-25 |
4 |
B |
$459.48 |
$6,056,955 |
I/I |
13,000 |
327,479 |
2.66 |
% |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2024-04-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,500 |
1,745,267 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2024-04-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
22,500 |
15,400 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,293 |
51,261 |
0 |
- |
|
116 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
